Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Raetz

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Pediatric Blood & Cancer|January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology GroupTodd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Pediatric Blood & Cancer|June 29, 2010
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortiumYoav Messinger, Paul Gaynon, Elizabeth Raetz, et al.
Leukemia|April 13, 2026
Adherence-enhancing intervention and relapse in childhood acute lymphoblastic leukemia: results from the Children's Oncology Group randomized trial ACCL1033Smita Bhatia, Lindsey Hageman, Yanjun Chen, et al.
Blood|February 24, 2006
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant ResearchMary Eapen, Elizabeth Raetz, Mei-Jie Zhang, et al.
Cancer Medicine|December 31, 2015
A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemiaSapna Kaul, Ernest Kent Korgenski, Jian Ying, et al.
Leukemia & Lymphoma|October 24, 2023
<i>SETD2</i> mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemiaGloria P Contreras Yametti, Gabriel Robbins, Ashfiyah Chowdhury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.
Blood|June 7, 2013
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology GroupWanda L Salzer, Barbara Asselin, Jeffrey G Supko, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Pediatric Blood & Cancer|July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium studyMatthew F Gorman, Lingyun Ji, Richard H Ko, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Pediatric Blood & Cancer|January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology GroupTodd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Pediatric Blood & Cancer|June 29, 2010
Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia (TACL) consortiumYoav Messinger, Paul Gaynon, Elizabeth Raetz, et al.
Leukemia|April 13, 2026
Adherence-enhancing intervention and relapse in childhood acute lymphoblastic leukemia: results from the Children's Oncology Group randomized trial ACCL1033Smita Bhatia, Lindsey Hageman, Yanjun Chen, et al.
Blood|February 24, 2006
Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant ResearchMary Eapen, Elizabeth Raetz, Mei-Jie Zhang, et al.
Cancer Medicine|December 31, 2015
A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemiaSapna Kaul, Ernest Kent Korgenski, Jian Ying, et al.
Leukemia & Lymphoma|October 24, 2023
<i>SETD2</i> mutations do not contribute to clonal fitness in response to chemotherapy in childhood B cell acute lymphoblastic leukemiaGloria P Contreras Yametti, Gabriel Robbins, Ashfiyah Chowdhury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.
Blood|June 7, 2013
Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology GroupWanda L Salzer, Barbara Asselin, Jeffrey G Supko, et al.
Pediatric Blood & Cancer|December 30, 2017
Identifying patient- and family-centered outcomes relevant to inpatient versus at-home management of neutropenia in children with acute myeloid leukemiaJulia E Szymczak, Kelly D Getz, Rachel Madding, et al.
Pediatric Blood & Cancer|July 27, 2010
Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium studyMatthew F Gorman, Lingyun Ji, Richard H Ko, et al.
Pageof 7